IL17A and cancer: On a functional level, in vivo studies in colitis-associated cancer were able to confirm that TGFβ relevantly contributed to the intratumoral accumulation of IL-17A+ IL-22+ CD4+ T cells and thereby obviously triggered IL-22-dependent tumor-promoting effects [140,141].